Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Detemir vs Glargine + Aspart in T2D
NCT00106366Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Mar 2005
- Primary completion
- Dec 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 3 trial of insulin detemir in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Mar 2005; status: completed.
02
Drugs
insulin detemir
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00106366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00106366.